Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Genes and Phenotype (GAP) A National Resource for Genotype-Phenotype Studies of Immunological and Inflammatory Pathways (GAP)

This study has been completed.
Sponsor:
Collaborators:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
University of Alabama at Birmingham
Information provided by (Responsible Party):
Peter Gregersen, North Shore Long Island Jewish Health System
ClinicalTrials.gov Identifier:
NCT01161056
First received: July 9, 2010
Last updated: September 9, 2015
Last verified: September 2015
  Purpose
The purpose of this study is to enrol generally healthy adults, who are asked to provide a blood sample, to study how the immune system works.

Condition
Immune System Diseases

Study Type: Observational
Official Title: Genes and Phenotype (GAP) A National Resource for Genotype-Phenotype Studies of Immunological and Inflammatory Pathways

Resource links provided by NLM:


Further study details as provided by Northwell Health:

Primary Outcome Measures:
  • Number of healthy participants enrolled [ Time Frame: 5 years ] [ Designated as safety issue: No ]
    This is a registry to enroll healthy individuals who are interested in being contacted about research studies they can participate in as a healthy control


Biospecimen Retention:   Samples With DNA
Blood sample will be processed to isolate DNA and peripheral blood mononuclear cells, which will be stored in our Biorepository.

Enrollment: 5000
Study Start Date: May 2009
Study Completion Date: April 2015
Primary Completion Date: April 2015 (Final data collection date for primary outcome measure)
Groups/Cohorts
Healthy Control Group

Detailed Description:

The primary purpose of this research is to develop a better understanding of how the immune system works. By studying immune function in many people, we will be able to determine the range of normal variation.

The second purpose is to enroll people who are willing to serve as comparisons in future research studies into the Genotype and Phenotype Research Registry (GAP Registry).

Volunteers are asked to provide information on age, ethnicity and medical history. Volunteers are asked to provide a blood sample of up to 100cc and allow us to contact you about additional studies.

  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Healthy Controls
Criteria

Inclusion Criteria:

  • Over age 18
  • Generally healthy

Exclusion Criteria:

  • History of autoimmune disease
  • History of chronic immunodeficiency or chronic viral infections such as Epstein Barr virus, hepatitis or HIV
  • Currently undergoing treatment for cancer
  • Current treatment with immuno-suppressant drugs
  • Pregnancy
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01161056

Locations
United States, New York
The Feinstein Institute for Medical Research
Manhasset, New York, United States, 11030
Sponsors and Collaborators
Northwell Health
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
University of Alabama at Birmingham
Investigators
Principal Investigator: Peter Gregersen, MD The Feinstein Institute for Medical Research
  More Information

Responsible Party: Peter Gregersen, Center Head, North Shore Long Island Jewish Health System
ClinicalTrials.gov Identifier: NCT01161056     History of Changes
Other Study ID Numbers: 09-081A  1RC2AR059092-01 
Study First Received: July 9, 2010
Last Updated: September 9, 2015
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Immune System Diseases

ClinicalTrials.gov processed this record on September 23, 2016